156 related articles for article (PubMed ID: 24175748)
1. Targeting the redox metabolism of Plasmodium falciparum.
Nepveu F; Turrini F
Future Med Chem; 2013 Oct; 5(16):1993-2006. PubMed ID: 24175748
[TBL] [Abstract][Full Text] [Related]
2. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum.
Müller S
Mol Microbiol; 2004 Sep; 53(5):1291-305. PubMed ID: 15387810
[TBL] [Abstract][Full Text] [Related]
3. Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones--a new strategy to combat malarial parasites.
Müller T; Johann L; Jannack B; Brückner M; Lanfranchi DA; Bauer H; Sanchez C; Yardley V; Deregnaucourt C; Schrével J; Lanzer M; Schirmer RH; Davioud-Charvet E
J Am Chem Soc; 2011 Aug; 133(30):11557-71. PubMed ID: 21682307
[TBL] [Abstract][Full Text] [Related]
4. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
5. Redox interactome in malaria parasite Plasmodium falciparum.
Tiwari S; Sharma N; Sharma GP; Mishra N
Parasitol Res; 2021 Feb; 120(2):423-434. PubMed ID: 33459846
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum.
Radfar A; Diez A; Bautista JM
Free Radic Biol Med; 2008 Jun; 44(12):2034-42. PubMed ID: 18397762
[TBL] [Abstract][Full Text] [Related]
7. 1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents.
Belorgey D; Lanfranchi DA; Davioud-Charvet E
Curr Pharm Des; 2013; 19(14):2512-28. PubMed ID: 23116403
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Plasmodium falciparum to glutamate dehydrogenase inhibitors--a possible new antimalarial target.
Aparicio IM; Marín-Menéndez A; Bell A; Engel PC
Mol Biochem Parasitol; 2010 Aug; 172(2):152-5. PubMed ID: 20399810
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
Qidwai T; Khan F
Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
[TBL] [Abstract][Full Text] [Related]
10. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
Ellekvist P; Colding H
Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of heme O in intraerythrocytic stages of Plasmodium falciparum and potential inhibitors of this pathway.
Simão-Gurge RM; Wunderlich G; Cricco JA; Cubillos EFG; Doménech-Carbó A; Cebrián-Torrejón G; Almeida FG; Cirulli BA; Katzin AM
Sci Rep; 2019 Dec; 9(1):19261. PubMed ID: 31848371
[TBL] [Abstract][Full Text] [Related]
12. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
Naughton JA; Nasizadeh S; Bell A
Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin and glutathione systems in Plasmodium falciparum.
Jortzik E; Becker K
Int J Med Microbiol; 2012 Oct; 302(4-5):187-94. PubMed ID: 22939033
[TBL] [Abstract][Full Text] [Related]
14. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin and glutathione system of malaria parasite Plasmodium falciparum.
Müller S; Gilberger TW; Krnajski Z; Lüersen K; Meierjohann S; Walter RD
Protoplasma; 2001; 217(1-3):43-9. PubMed ID: 11732337
[TBL] [Abstract][Full Text] [Related]
16. A proteomic glimpse into the effect of antimalarial drugs on Plasmodium falciparum proteome towards highlighting possible therapeutic targets.
Dousti M; Manzano-Román R; Rashidi S; Barzegar G; Ahmadpour NB; Mohammadi A; Hatam G
Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33202000
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the export pathway of malaria surface proteins.
Epp C; Deitsch K
Trends Parasitol; 2006 Sep; 22(9):401-4. PubMed ID: 16843728
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of Plasmodium falciparum schizonts reveals heparin-binding merozoite proteins.
Zhang Y; Jiang N; Lu H; Hou N; Piao X; Cai P; Yin J; Wahlgren M; Chen Q
J Proteome Res; 2013 May; 12(5):2185-93. PubMed ID: 23566259
[TBL] [Abstract][Full Text] [Related]
19. Biochemical studies of membrane bound Plasmodium falciparum mitochondrial L-malate:quinone oxidoreductase, a potential drug target.
Hartuti ED; Inaoka DK; Komatsuya K; Miyazaki Y; Miller RJ; Xinying W; Sadikin M; Prabandari EE; Waluyo D; Kuroda M; Amalia E; Matsuo Y; Nugroho NB; Saimoto H; Pramisandi A; Watanabe YI; Mori M; Shiomi K; Balogun EO; Shiba T; Harada S; Nozaki T; Kita K
Biochim Biophys Acta Bioenerg; 2018 Mar; 1859(3):191-200. PubMed ID: 29269266
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.
Jung SY; Zheng B; Choi YY; Soh BY; Kim SY; Park KI; Park H
Arch Pharm Res; 2009 Jun; 32(6):899-906. PubMed ID: 19557368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
